Animal Bacterial Infection Veterinary Drug: 10% Mapofloxacin Injection Broad-Spectrum Antibiotic

• Varieties: Parasite Disease Prevention Medicine
• Component: Chemical Synthetic Drugs
• Type: The First Class
• Pharmacodynamic Influential Factors: Combined Medication
• Storage Method: Prevent High or LowTemperature
• Veterinary Reg. No.: (2018) Veterinary Drug Production Certificate No.
• Model NO.: Marbofloxacin
• Specification: 100ml or Customized
• Trademark: CXBT & ShowVet
• Origin: Henan China
• Production Capacity: 50000bottle/Week

Product Description

Composition:

Each ml contains:

Marbofloxacin: 100mg

Excipients ad: 1ml

AdvaCare is a GMP manufacturer of Marbofloxacin Injection.

Marbofloxacin is a synthetic, broad-spectrum antibiotic under a class of fluoroquinolone drug. It is used in to treat a range of serious bacterial infections.

Marbofloxacin's primary mechanism of action is to inhibit the bacterial enzymes, which eventually leads to the death of the bacteria.

In cattle, it is used in the treatment of respiratory infections caused by susceptible strains of Pasteurella multocida, Mannheimia haemolytica and Histophilus somni. It is recommended in the treatment of acute mastitis caused by Echerichia coli strains susceptible to Marbofloxacin during the lactation period.

In pigs, it is used in the treatment of Metritis Mastitis Agalactia Syndrome (MMA syndrome, postpartum dysgalactia syndrome, PDS) caused by bacterial strains susceptible to Marbofloxacin.

Indications:
In cattle it is indicated in the treatment of respiratory infections caused by susceptible strains of Pasteurella multocida, Mannheimia haemolytica and Histophilus somni. It is recommended in the treatment of acute mastitis caused by Echerichia coli strains susceptible to marbofloxacin during the lactation period.
In pigs it is indicated in the treatment of Metritis Mastitis Agalactia Syndrome (MMA syndrome, postpartum dysgalactia syndrome, PDS) caused by bacterial strains susceptible to marbofloxacin.

 

Contra-indications:

Bacterial infections with resistance to other fluoroquinolones (cross resistance). Administration of medication to an animal previously found to be hypersensitive to marbofloxacin or other quinolone is contradicted.

Administration and Dosage:
The recommended dosage is 2mg/kg/day (1ml/50kg) of marbofloxacin injections given intramuscularly to the intended livestock or pet, any increase in dosage should be supervised by your animal care specialist. Marbofloxacin injection shouldn't be administered if any hypersensitivity is discovered.
Refer to an animal care specialist for guidelines on dosage. Do not exceed what they advise, and complete the full treatment, as stopping early can result in a recurrence or worsening of the problem.

Storage:
Store below 25ºC, in a cool and dry place, and protect from light.

 

Henan Chuangxin Biological Technology Co., Ltd. is a large joint-stock company integrating animal drug research and
development, production and sales, and after-sales service. In December 2012, the one-time high score passed the
acceptance of eight veterinary drug GMP production lines of the Ministry of Agriculture. The production dosage forms
involve powder/premix, terminally sterilized small-volume injection (including Chinese medicine extraction)/terminally
sterilized large-volume non- Intravenous injection (including traditional Chinese medicine extraction) / oral liquid solution
(including traditional Chinese medicine extraction), non-chlorine disinfectant (liquid), feed additives(Probiotics Green) and
Originally created China's leading Chinese medicine antiviral preparations, animal Chinese medicine extract preparations
such as Toad venom and Cantharidin. Known as the GMP standard model factory of veterinary drugs in Henan Province.